Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Kwang Chien Yee"'
Autor:
Anh Le Tuan Nguyen, Lei Si, John S Lubel, Nicholas Shackel, Kwang Chien Yee, Mark Wilson, Jane Bradshaw, Kerry Hardy, Andrew John Palmer, Christopher Leigh Blizzard, Barbara de Graaff
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Hepatocellular carcinoma (HCC) is the fastest increasing cause of cancer death in Australia. A recent Australian consensus guidelines recommended HCC surveillance for cirrhotic patients and non-cirrhotic chronic hepatitis B (CHB)
Externí odkaz:
https://doaj.org/article/88c307713f7e441c97586d9ef824669d
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 43, Iss 3, Pp 267-273 (2019)
Abstract Objective: Assess national and jurisdictional incidence and mortality trends for primary liver cancer in Australia. Methods: Analysis of Australian Cancer Incidence and Mortality data published in 2017 by the AIHW. Age‐standardised rates (
Externí odkaz:
https://doaj.org/article/e9635bb531c1441d8a491d5390319d4e
Publikováno v:
Applied Sciences, Vol 12, Iss 7, p 3341 (2022)
Advances in artificial intelligence in healthcare are frequently promoted as ‘solutions’ to improve the accuracy, safety, and quality of clinical decisions, treatments, and care. Despite some diagnostic success, however, AI systems rely on forms
Externí odkaz:
https://doaj.org/article/e6d08f70eff94569bca630a893ab84b9
Publikováno v:
Caring is Sharing – Exploiting the Value in Data for Health and Innovation ISBN: 9781643683881
Over the last decade, the explosion of “Big Data” and its fusion with AI has led many to believe that the development and integration of AI systems in healthcare will usher in a transformative revolution that democratises access to high quality h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed0759f330e536ca800094e56f15f43
https://doi.org/10.3233/shti230166
https://doi.org/10.3233/shti230166
Publikováno v:
Studies in health technology and informatics. 295
Inflammatory bowel disease (IBD) is a chronic relapsing and remitting illness. The presentation, diagnosis and management IBD are complex, and involve multi-disciplinary care with complex information requirements. The lack of an accurate and comprehe
Inflammatory bowel disease (IBD) is a chronic relapsing and remitting illness. The presentation, diagnosis and management IBD are complex, and involve multi-disciplinary care with complex information requirements. The lack of an accurate and comprehe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae13d6735661fa6a3c2a9a44d7f72768
https://doi.org/10.3233/shti220665
https://doi.org/10.3233/shti220665
Autor:
Christopher L. Blizzard, Barbara de Graaff, Kwang Chien Yee, Andrew J. Palmer, Anh Le Tuan Nguyen, Hoa Thi Thu Nguyen
Publikováno v:
Value in Health. 24:733-743
Objectives Many economic evaluations of hepatocellular carcinoma (HCC) screenings have been conducted; however, these vary substantially with regards to screening strategies, patient group, and setting. This review aims to report the current knowledg
AI augmented clinical diagnostic tools are the latest research focus in colorectal cancer (CRC) detection. While the opportunity presented by AI-enhanced CRC diagnosis is sound, this paper highlights how its effectiveness with respect to reducing CRC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88775a1aaed4b72e3d85653c25e1f6a1
https://doi.org/10.3233/shti220588
https://doi.org/10.3233/shti220588
Publikováno v:
Studies in health technology and informatics. 294
AI augmented clinical diagnostic tools are the latest research focus in colorectal cancer (CRC) detection. While the opportunity presented by AI-enhanced CRC diagnosis is sound, this paper highlights how its effectiveness with respect to reducing CRC
Publikováno v:
Clinics and research in hepatology and gastroenterology. 47(1)
The current "Gold Standard" colorectal cancer (CRC) screening approach of faecal occult blood test (FOBT) with follow-up colonoscopy has been shown to significantly improve morbidity and mortality, by enabling the early detection of disease. However,